{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT05505565",
            "orgStudyIdInfo": {
                "id": "IRB-300009480"
            },
            "organization": {
                "fullName": "University of Alabama at Birmingham",
                "class": "OTHER"
            },
            "briefTitle": "Tolerability, Acceptance, and Utility of Intermittent CGM Use in Youth With Prediabetes",
            "officialTitle": "Continuous Glucose Monitors in the Management of Youth With Prediabetes",
            "therapeuticArea": [
                "Endocrinology",
                "Other"
            ],
            "study": "tolerability-acceptance-and-utility-of-intermittent-cgm-use-in-youth-with-prediabetes"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-06",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2023-06-05",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2025-01-30",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2025-01-30",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2022-08-15",
            "studyFirstSubmitQcDate": "2022-08-15",
            "studyFirstPostDateStruct": {
                "date": "2022-08-17",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-06-12",
            "lastUpdatePostDateStruct": {
                "date": "2024-06-13",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "PRINCIPAL_INVESTIGATOR",
                "investigatorFullName": "Jessica Schmitt",
                "investigatorTitle": "Assistant Professor",
                "investigatorAffiliation": "University of Alabama at Birmingham"
            },
            "leadSponsor": {
                "name": "University of Alabama at Birmingham",
                "class": "OTHER"
            }
        },
        "oversightModule": {
            "oversightHasDmc": false,
            "isFdaRegulatedDrug": false,
            "isFdaRegulatedDevice": true,
            "isUsExport": false
        },
        "descriptionModule": {
            "briefSummary": "We are evaluating whether intermittent use of continuous glucose monitors (CGMs) in addition to standard nutritional counseling and physical activity counseling is associated with improved metabolic health for youth with pre-diabetes (PD).",
            "detailedDescription": "The purpose of this research study is to test if CGMs are tolerable to youth with pre-diabetes (PD) and their caregivers. We are also evaluating if CGMs add benefit to standard treatment in youth with prediabetes. The CGM in question, Abbott Freestyle Libre 2 is approved by the Food and Drug Administration (FDA) to treat patients aged 4 and up with diabetes. We want to determine if this CGM may benefit people who have PD. People who enter the study will either receive standard medical care for prediabetes or receive standard medical care for prediabetes plus use a CGM for 2 weeks each month to receive real-time biofeedback on their glucose levels during the day.\n\nThere will be 3 visits over a 6-month period, baseline, 3-month, and 6-month visits. At each visit fasting labs will be obtained including: complete metabolic panel, lipid panel, pro-insulin, c-peptide, insulin. Anthropomorphics including body mass index, waist circumference, and hip circumference will be monitored."
        },
        "conditionsModule": {
            "conditions": [
                "PreDiabetes",
                "Obesity",
                "Insulin Resistance"
            ],
            "keywords": [
                "pediatrics",
                "prediabetes",
                "obesity"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "NA"
            ],
            "designInfo": {
                "allocation": "RANDOMIZED",
                "interventionModel": "PARALLEL",
                "interventionModelDescription": "Randomized, non-blinded, parallel, intervention vs control group",
                "primaryPurpose": "PREVENTION",
                "maskingInfo": {
                    "masking": "NONE"
                }
            },
            "enrollmentInfo": {
                "count": 33,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "CGM + Traditional Counseling",
                    "type": "EXPERIMENTAL",
                    "description": "Subjects in this arm will receive intermittent CGM to be used for 2-weeks each month for the 6-month study period. They will be required to wear a CGM during baseline, 3-month, and 6-month periods. Additional CGM sensors will be supplied for months 1, 2, 4, and 5 and will be optional. They will be provided with a Sworkit(R) account to monitor physical activity completed through the Sworkit(R) website/platform.",
                    "interventionNames": [
                        "Device: Abbott Freestyle Libre 2",
                        "Other: Standard physical activity and nutritional counseling for prediabetes management"
                    ]
                },
                {
                    "label": "Control",
                    "type": "ACTIVE_COMPARATOR",
                    "description": "Subjects in this arm will receive standard medical care for pre-diabetes. They will be provided with a Sworkit(R) account to monitor physical activity completed through the Sworkit(R) website/platform.",
                    "interventionNames": [
                        "Other: Standard physical activity and nutritional counseling for prediabetes management"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DEVICE",
                    "name": "Abbott Freestyle Libre 2",
                    "description": "Subjects will be educated on use of Abbott Freestyle Libre 2 and educated on how daily activities impact glucose.",
                    "armGroupLabels": [
                        "CGM + Traditional Counseling"
                    ]
                },
                {
                    "type": "OTHER",
                    "name": "Standard physical activity and nutritional counseling for prediabetes management",
                    "description": "Subjects will be advised on recommendations for nutrition and activity goals for preventing progression of prediabetes.",
                    "armGroupLabels": [
                        "CGM + Traditional Counseling",
                        "Control"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "CGM Acceptability",
                    "description": "Caregiver and patient acceptability of CGM use",
                    "timeFrame": "6 months"
                },
                {
                    "measure": "Progression of prediabetes",
                    "description": "change in hemoglobin A1c",
                    "timeFrame": "6 months"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Insulin sensitivity",
                    "description": "HOMA-IR, fasting c-peptide, fasting pro-insulin",
                    "timeFrame": "6 months"
                },
                {
                    "measure": "Hyperlipidemia",
                    "description": "LDL, triglyceride, HDL, total cholesterol measurements",
                    "timeFrame": "6 months"
                },
                {
                    "measure": "Transaminitis",
                    "description": "AST, ALT",
                    "timeFrame": "6 months"
                },
                {
                    "measure": "Glycemic metrics",
                    "description": "CGM data including: time in target range, time above target range, post-prandial glucose excursion",
                    "timeFrame": "6 months"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* Age 14 or older\n* English-speaking\n* stable metformin dose for 1 month prior to enrollment or no metformin use\n* baseline A1c of 5.7-6.4%\n* tanner stage 3 or above\n* BMI \\> = 85% for age\n\nExclusion Criteria:\n\n* BMI \\< 85% for age\n* chronic steroid use\n* diagnosis of type 1 diabetes, type 2 diabetes, other forms of diabetes\n* current or history of malignancy",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "14 Years",
            "stdAges": [
                "CHILD",
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Jessica A Schmitt, MD",
                    "role": "CONTACT",
                    "phone": "2056385033",
                    "email": "jessicaschmitt@uabmc.edu"
                },
                {
                    "name": "Ambika Ashraf, MD",
                    "role": "CONTACT",
                    "phone": "2056389107",
                    "email": "AAshraf@uabmc.edu"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Jessica A Schmitt, MD",
                    "affiliation": "University of Alabama at Birmingham",
                    "role": "PRINCIPAL_INVESTIGATOR"
                }
            ],
            "locations": [
                {
                    "facility": "Children's of Alabama",
                    "status": "RECRUITING",
                    "city": "Birmingham",
                    "state": "Alabama",
                    "zip": "35233",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Jessica A Schmitt, MD",
                            "role": "CONTACT",
                            "phone": "205-638-5033",
                            "email": "jessicaschmitt@uabmc.edu"
                        },
                        {
                            "name": "Ambika Ashraf, MD",
                            "role": "CONTACT",
                            "phone": "2056389107",
                            "email": "AAshraf@uabmc.edu"
                        }
                    ],
                    "geoPoint": {
                        "lat": 33.52066,
                        "lon": -86.80249
                    }
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "NO"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000007333",
                    "term": "Insulin Resistance"
                },
                {
                    "id": "D000011236",
                    "term": "Prediabetic State"
                },
                {
                    "id": "D000018149",
                    "term": "Glucose Intolerance"
                }
            ],
            "ancestors": [
                {
                    "id": "D000006946",
                    "term": "Hyperinsulinism"
                },
                {
                    "id": "D000044882",
                    "term": "Glucose Metabolism Disorders"
                },
                {
                    "id": "D000008659",
                    "term": "Metabolic Diseases"
                },
                {
                    "id": "D000003920",
                    "term": "Diabetes Mellitus"
                },
                {
                    "id": "D000004700",
                    "term": "Endocrine System Diseases"
                },
                {
                    "id": "D000006943",
                    "term": "Hyperglycemia"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M12701",
                    "name": "Obesity",
                    "relevance": "LOW"
                },
                {
                    "id": "M14117",
                    "name": "Prediabetic State",
                    "asFound": "Prediabetes",
                    "relevance": "HIGH"
                },
                {
                    "id": "M20295",
                    "name": "Glucose Intolerance",
                    "asFound": "Prediabetes",
                    "relevance": "HIGH"
                },
                {
                    "id": "M10370",
                    "name": "Insulin Resistance",
                    "asFound": "Insulin Resistance",
                    "relevance": "HIGH"
                },
                {
                    "id": "M9997",
                    "name": "Hyperinsulinism",
                    "relevance": "LOW"
                },
                {
                    "id": "M11639",
                    "name": "Metabolic Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M25403",
                    "name": "Glucose Metabolism Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M7115",
                    "name": "Diabetes Mellitus",
                    "relevance": "LOW"
                },
                {
                    "id": "M7862",
                    "name": "Endocrine System Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M9994",
                    "name": "Hyperglycemia",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC18",
                    "name": "Nutritional and Metabolic Diseases"
                },
                {
                    "abbrev": "BC23",
                    "name": "Symptoms and General Pathology"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BC19",
                    "name": "Gland and Hormone Related Diseases"
                }
            ]
        }
    },
    "hasResults": false
}